In healthy conditions, SGLT2 is minimally expressed in liver cells; however, in the context of MASH, hepatocyte SGLT2 expression has been reported to increase, possibly triggered by hyperglycemia and inflammation. This evidence concerns the gene SLC5A2 and Hyperglycemia.